112 related articles for article (PubMed ID: 16427378)
21. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
[TBL] [Abstract][Full Text] [Related]
22. Therapy of hepatitis C: from empiricism to eradication.
Pawlotsky JM
Hepatology; 2006 Feb; 43(2 Suppl 1):S207-20. PubMed ID: 16447262
[TBL] [Abstract][Full Text] [Related]
23. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
Bräu N
J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
[TBL] [Abstract][Full Text] [Related]
24. Treatment of chronic hepatitis C in southern Taiwan.
Chuang WL; Yu ML; Dai CY; Chang WY
Intervirology; 2006; 49(1-2):99-106. PubMed ID: 16166797
[TBL] [Abstract][Full Text] [Related]
25. Update on the treatment of chronic hepatitis C in HIV-infected patients.
Soriano V; Barreiro P; Martin-Carbonero L; Vispo E; Garcia-Samaniego J; Labarga P; Gonzalez-Lahoz J
AIDS Rev; 2007; 9(2):99-113. PubMed ID: 17694677
[TBL] [Abstract][Full Text] [Related]
26. Clinical trial results of peginterferons in combination with ribavirin.
Craxi A; Licata A
Semin Liver Dis; 2003; 23 Suppl 1():35-46. PubMed ID: 12934167
[TBL] [Abstract][Full Text] [Related]
27. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
28. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
Sterling RK; Sulkowski MS
Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
[TBL] [Abstract][Full Text] [Related]
31. Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders.
Sauleda S; Juárez A; Esteban JI; Altisent C; Ruiz I; Puig L; Esteban R; Guardia J
Hepatology; 2001 Nov; 34(5):1035-40. PubMed ID: 11679976
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.
Rodríguez-Torres M; Rodríguez-Orengo JF; Ríos-Bedoya CF; Fernández-Carbia A; González-Lassalle E; Salgado-Mercado R; Marxuach-Cuétara AM
J Clin Virol; 2007 Jan; 38(1):32-8. PubMed ID: 17064957
[TBL] [Abstract][Full Text] [Related]
33. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
[TBL] [Abstract][Full Text] [Related]
34. The natural history and antiviral treatment of hepatitis C in haemophilia.
Lee C; Dusheiko G
Haemophilia; 2002 May; 8(3):322-9. PubMed ID: 12010429
[TBL] [Abstract][Full Text] [Related]
35. Management of HCV-Related Liver Disease in Hemophilia and Thalassemia.
Rumi MG; Di Marco V; Colombo M
Semin Liver Dis; 2018 May; 38(2):112-120. PubMed ID: 29871018
[TBL] [Abstract][Full Text] [Related]
36. An emerging role for interferon in haemophiliacs with chronic hepatitis C?
Aguilar C; Lucia JF; Simón MA
Haemophilia; 2001 Jan; 7(1):6-8. PubMed ID: 11136373
[TBL] [Abstract][Full Text] [Related]
37. Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors.
Honda T; Katano Y; Toyoda H; Hayashi K; Ishigami M; Nakano I; Goto H; Yamamoto K; Takamatsu J
J Clin Psychiatry; 2008 Apr; 69(4):679-80. PubMed ID: 18507491
[No Abstract] [Full Text] [Related]
38. Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohort.
Eyster ME; Kong L; Li M; Schreibman IR
Am J Hematol; 2016 Sep; 91(9):E335-40. PubMed ID: 27214557
[TBL] [Abstract][Full Text] [Related]
39. Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin.
Yamamoto K; Honda T; Matsushita T; Kojima T; Takamatsu J
J Thromb Haemost; 2006 Feb; 4(2):469-70. PubMed ID: 16420581
[No Abstract] [Full Text] [Related]
40. Human leukocyte interferon-alpha treatment for chronic HCV-related hepatitis in hemophilic patients previously intolerant to other interferons-alpha.
Dughera L; Battaglia E; Serra AM; Tibaudi D; Buonafede G; Navino M; Schinco P; Tamponi G; Emanuelli G
Dig Dis Sci; 2002 Feb; 47(2):427-31. PubMed ID: 11855562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
